Yang Rui arrived at Astra's office area half an hour in advance, and sat quietly in the lounge and read his manuscript.

Giving lectures in large companies is very polarizing. Sometimes, some professors are extra hyped, and sometimes they get special ridicule.

Having a good title is usually easier to get the former.

For example, professors at Harvard University, professors at Stanford University, or academicians at Trinity College, Cambridge, etc. are always more convincing, but not absolutely.

A good example is a professor at Stanford University. Due to distance, Silicon Valley startups often invite Stanford professors to lectures, but those who go there may not necessarily be recognized by Silicon Valley people. Although many Silicon Valley people are from the computer department of Stanford University, they still try very hard to mock them. After years of hard work, those Silicon Valley people with rich income are no longer what they look like in schools, and they have their own understanding of the true strength of Stanford University professors.

At this time, professors at Stanford University do not necessarily stand at the forefront of the industry.

Moreover, the so-called cutting-edge theories they proposed may not necessarily be recognized by the industry.

The founders of Cisco, Bosack and Rena, can be regarded as examples of the industry. They are experts in computer theory and have made top-notch practices. The routers they created laid the initial foundation for the development of network technology.

But if you look at the identities of the two, you will know that it is not easy for them to do all this. Bosack is the director of the Computer Center of Stanford Computer Department, and Sandy Lena is the head of the Computer Center of the Business School. In the era of underdeveloped Silicon Valley, they were basically the first-class scholars in the theoretical world.

Giving a lecture to Astra is not an easy task.

Such large pharmaceutical companies cannot be simply regarded as the level of the industry. Among such a large number of companies, they are also hidden.

Of course, native pharmaceutical companies have no sense of existence in front of scholars like Yang Rui. They belong to the lowest level of the scientific research contempt chain. Whether they are good or poor students, whether they are undergraduate or doctoral students, if they graduate and enter pharmaceutical companies, they will basically not make any achievements at the forefront of science.

Even if there are some special cases, they are not usually recognized by the mainstream scientists.

The goal of pharmaceutical companies is to find compounds for known targets and put them in the field of G-protein coupled receptors. The main work of pharmaceutical companies' scholars is to pick up a certain target in systematic research after cutting-edge scientists have done systematic research. As the research object, it can be said that researchers in the industry are not even second-tier scientists, and can only be called third-tier, so-called results transformers.

However, companies like Astra, in addition to native pharmaceutical companies, there are also first-tier and second-tier researchers. Some powerful companies can even recruit Nobel Prize winners.

The 2008 Nobel Prize in Biology was awarded to Laldhausen, who won the award for researching the tumorivirus that causes cervical cancer. He has a close relationship with AstraZeneca and can be regarded as one-third of AstraZeneca people.

This time, the Nobel Prize is also the most suspected Nobel Prize fraud case that Yang Rui knows - although there is no conclusive evidence, AstraZeneca Pharmaceuticals did play a key role in this Nobel Prize. A director of AstraZeneca is a member of the Nobel Prize, and before winning the award, he acquired a company that developed key components of the HPV vaccine and will charge huge patent fees for it.

In addition, the chairman of the five-member committee responsible for selecting Nobel Prize candidates, served as AstraZeneca's fee consultant in 2006. One of the members of the 50-member committee responsible for voting, and also took AstraZeneca's money in the name of the consultant.

AstraZeneca also sponsored two institutions and subordinate promotion departments of the Nobel Prize Committee in the past few years. In addition, several members of the Nobel Prize Committee admitted that they were invited to go to China for a fee to introduce to Chinese officials how the candidates were selected - that was after 2005, which shows that China had already had a peek at the Nobel Prize Awards at that time, or, AstraZeneca had used the China platform.

In short, large pharmaceutical companies are like large military-industrial enterprises or large energy enterprises, all of which are organisms with huge energy. Their roles in world affairs are stronger than most small governments in Asia, Africa and Latin America.

However, large pharmaceutical companies are also complex complex conflicts. They have a history of dozens or hundreds of years. The founders have gone. It is difficult for the remaining professional managers and shareholders to find a dominant one. They are not a director or chairman, and they can make sure to decide on something major.

Yang Rui needs to prove his strength even more so that he can get on the ride.

In front of the Nobel Prize, everyone is equal, except Sweden.

"Mr. Yang Rui, the time is up." Pulitzer came to the lounge and said in a calm voice.

Yang Rui stood up steadily, smiled, and asked, "Are there many people coming?"

"There are about 60 people," Pulitzer explained, "Sweden is a country with a relatively small population. It rarely gathers a lot of people like China."

Yang Rui was stunned for a moment and couldn't help laughing.

Pulitzer knew that he had said the wrong thing and couldn't help feeling a little embarrassed.

Yang Rui coughed and said, "60 people are very satisfying."

He is preparing to explain academic issues to the researchers, and there are many people who can get a class together. To be honest, now that an academic seminar on G-protein coupled receptors is held in China, there are probably no 30 scholars who can understand what he is talking about. What he says is even worse, fifteen may be barely enough.

Although Wang Qi can see it with his head raised, it takes courage and luck to be able to walk under the king's flag while knee-length blood.

More than 60 people sat neatly in a classroom-like conference room. Each of them had a chair, which was also neatly arranged.

It's really neat.

Yang Rui stood on the podium and could see these chairs as if they were military parades, with horizontal screens and vertical screens.

Moreover, unlike domestic lectures, people will deliberately sit or prefer to sit in the back.

The Swedes sat one by one from front to back, from left to right, and each chair was nervously close to each other.

The chairs are folding chairs, so there are no handles, which makes the chair array that forms a large square look a little crowded. However, everyone, Swedes sit upright, with their chests raised, not only to make their position unique, but also try not to have physical contact with others.

If it weren't for knowing that this was my temporary request, Yang Rui really thought they had been rehearsed.

Of course, it can also be said that they have been rehearsed, and the Swedes have managed this way in collectively since childhood.

In addition to the employees of Astra Company, several members of the Chinese delegation also came to attend the lectures, and there was only one row in total.

Yang Rui planned to teach in English, so he would not use it if he didn't understand it.

In fact, you don’t have to listen to English if you understand it. Yang Rui’s lecture content has no intersection with the research directions of most people.

"I want to talk about G protein-coupled receptors and G proteins today." Yang Rui opened the lecture notes on the table, and said without looking at them. He said: "I want to make a prediction first. In 30 years, drugs targeting G protein-coupled receptors will reach 50% of the total number of modern drugs. In other words, when pharmaceutical companies develop new drugs in the future, at least one of each two new drugs is developed with G protein-coupled receptors as the target..."

The Swedes, who were originally very quiet, suddenly became less quiet.

As a disciplined nation, Swedes are very similar to Japanese people and they both pay attention to not causing trouble to others. However, at this time, some people still couldn't help but shout, "How is that possible?"

This is not a question, and Yang Rui did not have the desire to answer, but continued: "One of the two new drugs is the G-protein-coupled receptor target, which is actually not enough, because what I said is 50% of the total number of modern drugs... But let's not talk about the future today, let's talk about what we can do with G-protein-coupled receptors now."

After Yang Rui said this, everyone calmed down.

For pharmaceutical companies researchers, "what can be done" is a real thing.

At this time, Yang Rui was like a pig slaughter. The pharmaceutical company was a catering company. They needed to understand how the pig is divided now and what is the most suitable place for each part?

In the end, whether the ribs are used for soup or sweet and sourness, and whether the fat meat is used for refining or refilling, it depends on the quality of the meat.

Of course, only pharmaceutical companies of Astra are so particular. It is normal to do whatever you want after waiting.

Yang Rui looked down at his lecture notes and said, "My ion channel laboratory has done in-depth research on G-protein coupled receptors, but this content is not what I want to talk about today. I want to start from a new perspective. I named it the dynamic mass retest method. This method was considered in my spare time. It is a small problem, but it is very useful. At present, the most appropriate thing is that it can analyze the drug effects of G-protein coupled receptors in primary human cells."

As soon as the word "drug effect" came out, the neatly tidy squares suddenly rose and fell like waves.

That was the whispering movements of researchers.
Chapter completed!